has been cited by the following article(s):
[1]
|
The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways
Naunyn-Schmiedeberg's Archives of Pharmacology,
2020
DOI:10.1007/s00210-020-01863-9
|
|
|